Cresco Labs reports November 6 results: Cresco Labs stock has a negative 1.96 P/ E ratio

Published on 10/15/2026 at 22:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cresco Labs will report third-quarter results on November 6, 2026. Cresco Labs stock costs EUR 0.55 on October 15, 2026 at 10:13 p.m. CEST.

Results date and operating metrics

Cresco Labs scheduled third-quarter results for November 6, 2026.
Second-quarter revenue reached USD 173.34 million, up 15.00 percent sequentially.
Cresco Labs stock traded at EUR 0.55 at 10:13 p.m. CEST at Lang & Schwarz on October 15, 2026.
Market capitalization stood at CAD 311.6 million on October 15, 2026.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs has scheduled its third-quarter 2026 results for November 6, 2026, giving investors the next fixed date after a second quarter with USD 173.34 million in revenue. The stock traded at EUR 0.55 at Lang & Schwarz on October 15, 2026 at 10:13 p.m. CEST.

November 6 is the next date

According to Business Wire on October 15, 2026, Cresco Labs will publish results for the quarter ended September 30, 2026 before the market opens, followed by a conference call at 8:30 a.m. ET. The date is also the next scheduled checkpoint for revenue, margins and cash generation.

Revenue reached USD 173.34 million

The latest reported period was the second quarter of 2026. ScanX News reported on October 6, 2026 that revenue rose 15.00 percent sequentially to USD 173 million, while adjusted EBITDA increased 20.00 percent sequentially to USD 40 million. Adjusted gross profit reached USD 89 million, equal to a 52.00 percent margin. The standardized financial statement reports USD 173.34 million of revenue and USD 16.80 million of net income for the same period.

Price position and valuation

Cresco Labs stock traded at EUR 0.55 at Lang & Schwarz on October 15, 2026 at 10:13 p.m. CEST. The bid was EUR 0.53 and the ask was EUR 0.56. On the Canadian listing, the stock was last quoted at CAD 0.88 on October 15, 2026 at 3:50 p.m. ET, while the 52-week range was CAD 0.87 to CAD 3.12. The current Canadian quote places the stock 71.79 percent below its 52-week high.

Market value and business scale

Cresco Labs had a market capitalization of CAD 311.6 million on October 15, 2026 and a negative price-to-earnings ratio of 1.96. The company operates a vertically integrated cannabis business across eight states, combining branded products with Sunnyside dispensaries. Its investor-relations overview says the company was founded in 2013 and employs thousands of people.

Comparison with peers

Cresco Labs (CSE, CAD): P/E -1.96, market capitalization CAD 311.6 million
Green Thumb Industries (CSE, CAD): minus 1.09 percent, P/E 11.70, market capitalization CAD 1.98 billion

What comes next for the stock

The October 30, 2026 annual and special meeting is another dated corporate milestone, while the November 6 results release should provide the next operating update. The second-quarter figures showed revenue growth alongside a 52.00 percent adjusted gross margin, but the valuation data still reflect a loss-making earnings base.

Trading price in euros

The euro quote stood at EUR 0.55 at Lang & Schwarz on October 15, 2026 at 10:13 p.m. CEST. The latest Canadian listing quote was CAD 0.88 on October 15, 2026 at 3:50 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Cresco Labs stock.